biotx
Phase 2By testing every gene across all human tissues using large-scale Mendelian randomization and colocalization across thousands of diseases and biomarkers, we generate billions of causal data points linking genes to biological outcomes.
Founded
2018
Focus
AI / Machine Learning
About
By testing every gene across all human tissues using large-scale Mendelian randomization and colocalization across thousands of diseases and biomarkers, we generate billions of causal data points linking genes to biological outcomes.
Funding History
2Total raised: $23.5M
Series A$20MAndera PartnersNov 15, 2023
Seed$3.5MHigh-Tech GründerfondsMar 15, 2022
Company Info
TypePrivate
Founded2018
LocationMunich, Germany
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile